Vigabatrin Powder, For Solution
Product Images NDC 70771-1742

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 70771-1742). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 01)

Chemical structure of vigabatrin, showing its molecular arrangement with amino, carboxyl, and vinyl functional groups.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 02)

A cumulative distribution plot showing the percentage reduction in seizure frequency versus the percentage of patients treated with different daily doses of vigabatrin (VGB) compared to placebo. The graph depicts varying improvements in seizure frequency with 1g/day, 3g/day, and 6g/day vigabatrin doses relative to placebo, with axes labeled for improvement/worsening and reduction percentage.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 03)

A cumulative percentage plot graph showing the reduction in seizure frequency among patients. The vertical axis represents the percentage reduction in seizure frequency, ranging from -100% (worsening) to +100% (improvement). The horizontal axis shows the percentage of patients, descending from 100% to 0%. Two curves compare placebo and 3g/day vigabatrin (VGB), illustrating treatment effects on seizure frequency.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 04)

The image shows a vial labeled Vigabatrin for Oral Solution, USP 500 mg, distributed by Zydus. It is placed next to a glass with a spoon and a pair of scissors, along with two syringes. The vial is intended for oral use, with a 500 mg strength clearly visible on the label.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 05)

An instructional diagram of an oral syringe showing labeled parts including the tip, dosage indicators on the barrel, barrel, bottom of the white plunger, and plunger. The image highlights the components for accurately measuring and administering oral liquid medication.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 06)

An illustration showing a hand pouring vigabatrin oral solution, USP 500 mg from a bottle labeled with strength and manufacturer, into a clear glass container. The liquid appears clear as it is being dispensed.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 07)

An illustration labeled Figure B shows two clear glass cups placed side by side on a flat surface. The left cup is partially filled with a clear liquid, while the right cup is empty. The image appears to demonstrate a comparison or measurement involving liquid in the cups.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 08)

An instructional illustration labeled 'Figure C' showing a gloved hand holding a syringe being immersed into a beaker filled with liquid, likely demonstrating a step in preparing an oral solution from powder.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 09)

An instructional illustration labeled 'Figure D' showing a hand holding a syringe or oral dispenser with a measurement scale, likely used for measuring and administering a liquid medication dose.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 10)

An instructional illustration labeled 'Figure E' showing a hand holding a syringe with a liquid level marked at the 10 mL line, indicated by an arrow and text. It demonstrates how to measure 10 mL of liquid in the syringe.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 11)

An instructional illustration labeled Figure F showing a hand holding a syringe dispensing liquid into a glass container. The image appears to demonstrate the preparation or administration step involving oral solution.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 12)

An instructional image labeled 'Figure G' showing a hand holding a spoon stirring a clear liquid in a transparent glass cup. The image likely demonstrates the preparation or mixing of an oral solution.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 13)

An instructional illustration labeled 'Figure H' showing a hand holding a syringe inside a clear glass container. The image appears to demonstrate a step related to drug preparation or administration involving a syringe and a liquid vessel.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 14)

An instructional illustration showing a hand holding and preparing an oral dosing syringe. The syringe has measurement markings and appears to be used for administering a liquid medication orally.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 15)

An instructional illustration showing an adult hand administering oral medication to a baby using an oral syringe inserted into the baby's mouth. The baby is seated and has a small hair clip on the side of her head.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 16)

Packaging label for Vigabatrin for Oral Solution, USP, 500 mg powder for solution. The label shows a single packet with directions to mix with 10 mL of water before use. The labeler is Zydus Lifesciences Limited, and it includes storage instructions, the NDC 70771-1742, and a barcode.*

FDA Label Image

Image (B77af446 840e 4ac9 A29d D426f430da86 17)

Packaging label for Vigabatrin for Oral Solution, USP 500 mg powder for solution in 50 packets. The label shows the product name, strength, dosage form, and manufacturer Zydus Lifesciences Limited. Directions for use, storage instructions, and barcode are visible on the label layout.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.